Company intelligence / Profile preview

Eko Health

Emeryville, California, United Stateseko.com ↗

Ownership: Private
Development stage: Commercial

Overview

Eko Health has developed FDA-cleared digital stethoscopes integrated with AI algorithms for early detection of heart and lung diseases. Clinical studies have validated the accuracy of its low ejection fraction algorithm for heart failure screening. The company’s products are used by hundreds of thousands of clinicians worldwide to improve early diagnosis in both primary care and specialist settings[2][3][6].

Therapeutic areas: PulmonologyCardiovascular
Modalities: DeviceSoftwareArtificial intelligence (AI) analysis platform
Industry: Physiological Monitoring

Partnerships

Mayo Clinic (algorithm co-development)AstraZeneca[10]Sutter Health[5]NCH Healthcare System[7]LSU/Guthrie/Essenita as customers[9]Strategic partnership with 3M for Littmann® CORE digital stethoscope integration[2][3]

Beyond the preview

Go deeper on Eko Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eko Health.

Explore the full profile